Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Scott Smith
Age : 48
Public asset : 122,130 USD
Country of residence : Unknown
Linked companies : Ascendis Pharma A/S

Biography of Scott Smith 
Presently, Scott Thomas Smith occupies the position of Chief Financial Officer & Senior Vice President of Ascendis Pharma A. He previously occupied the position of Director-Healthcare Investment Banking Group at Wedbush Securities, Inc. and Director-Global Healthcare Investment Banking at Merrill Lynch, Pierce, Fenner & Smith, Inc. Mr. Smith received an undergraduate degree from Claremont McKenna College and an MBA from Stanford Graduate School of Business.


Current positions of Scott Smith 
Holdings of Scott Smith 
Scott Smith : Personal Network 
Most Read News 
01/25Musk says China rivals 'work hardest, smartest'
RE
01/27Wood's ARK Innovation Fund on pace for best month ever as battered stocks surge
RE
01/26LVMH's Arnault brushes off succession question
RE
01/26Bill Ackman says Hindenburg's report on Adani Group 'highly credible'
RE
02/02Billionaire Cohen builds stake in Nordstrom, urges board shakeup
RE
02/03Exclusive-BlackRock sustainability chief Bodnar to join Bezos Earth Fund - memo
RE
02/03U.S. jury finds Tesla and Musk not liable in case over take-private tweet
RE
02/03SoftBank Q3 seen under pressure from tech weakness, Arm IPO eyed
RE
02/01Sony Group CFO Totoki to succeed Yoshida as president - Nikkei
RE
01/31Italy considers replacements for Starace as Enel CEO, sources say
RE
More news


© 2023 People and Ownership :   
Scott Smith : Connections 


Latest news about Scott Smith 
01/10Transcript : BioAtla, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 03:00 PM
CI
01/10BioAtla Sees Dosing of First Patient in Mid-Stage Part 2 Study in Soft Tissue Cancer This Quarter
MT
2022Viatris Inc. Announces Changes to its Board
CI
2022Prime Drills Multiple Bonanza and High-Grade Intercepts At Guadalupe Including 33.2 gpt Au and 1,072 gpt Ag over 2.0 Metres
CI
2022Transcript : Ascendis Pharma A/S - Special Call
CI
2022Transcript : SoundHound AI, Inc., Q3 2022 Earnings Call, Nov 10, 2022
CI
2022Transcript : BioAtla, Inc., Q3 2022 Earnings Call, Nov 03, 2022
CI
More news